Literature DB >> 36172069

Comment to the Letter to the Editor entitled "Lithium in drinking water and suicide risk" by Tomoyuki Kawada.

Antonina Luca1, Maria Luca2.   

Abstract

Entities:  

Year:  2022        PMID: 36172069      PMCID: PMC9489887          DOI: 10.17179/excli2022-5227

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.022


× No keyword cloud information.



Lithium is a metal naturally present in the Earth's crust. It is contained in traces in all soils and in higher amount in grains and vegetables. Since the mid-20th century, due to its proven efficacy in a plethora of psychiatric disturbances, including bipolar disorder (Fountoulakis et al., 2022[4]), recurrent unipolar depression (Undurraga et al., 2019[9]), suicide (Del Matto et al., 2020[2]; Girlanda et al., 2014[5]) and personality disorders (Luca et al., 2012[7]), lithium carbonate still represents one of the most prescribed drugs in psychiatry. Interestingly, although the oral therapeutic doses of lithium ranges from 600 to 1200 mg per day, previous studies suggested that the beneficial effect of lithium as mood stabilizer may be exerted at significantly lower doses, such as those naturally found in the environment (Young, 2009[10]). Actually, several ecological studies have assessed the association between the presence of lithium in drinking water and suicide risk in the general population, generally reporting an inverse association, particularly in men (Barjasteh-Askari et al., 2020[1]). In the Letter to the Editor entitled “Lithium in drinking water and suicide risk”, Tomoyuki Kawada (2022[6]) called for caution when interpreting ecological data, because associations recorded at a population-based level may not exert the same effect on an individual-based level. We strongly agree with Kawada's considerations. Moreover, although the inverse association between lithium concentration and suicide risk has been more frequently confirmed in men, the aforementioned studies did not perform a sex-stratified analysis to better describe the phenomenon. The explanation of the reported sex-related difference in lithium associated lower risk of suicide is far to be easy to delineate. Lithium bioavailability is in fact influenced by gastric secretions, weight, body fat percentage, hepatic metabolism and renal elimination and sex hormones (Flores-Ramos et al., 2017[3]). Furthermore, the higher incidence of suicide among men, regardless lithium intake, should be considered when interpreting these data. Finally, considering that suicide represents the result of different genetic, biological, demographic, psychiatric and environmental factors (McMahon et al., 2022[8]), the role of potentially confounder variables (i.e. economic availability, marital status, personality disorders, previous suicide attempts, previous psychiatric diagnosis…) in the association between water lithium intake and suicide risk should not be underestimated. In light of these aspects, risk-benefit considerations must be made when hypothesizing the supplementation of tap water with low concentration of lithium. Indeed, despite this procedure would represent a cheap and potentially beneficial opportunity to reduce suicide risk, lithium safety for pregnant women, people already assuming lithium carbonate and people suffering from thyroid or kidney disorders must be carefully considered.

Declaration

Conflict of interest

The authors declare that they have no conflict of interest.

Financial disclosures

None.
  10 in total

Review 1.  Is it important to consider the sex of the patient when using lithium or valproate to treat the bipolar disorder?

Authors:  Mónica Flores-Ramos; Philippe Leff; Alonso Fernández-Guasti; Claudia Becerra Palars
Journal:  Pharmacol Biochem Behav       Date:  2016-02-14       Impact factor: 3.533

Review 2.  Lithium and suicide prevention in mood disorders and in the general population: A systematic review.

Authors:  L Del Matto; M Muscas; A Murru; N Verdolini; G Anmella; G Fico; F Corponi; A F Carvalho; L Samalin; B Carpiniello; A Fagiolini; E Vieta; I Pacchiarotti
Journal:  Neurosci Biobehav Rev       Date:  2020-06-16       Impact factor: 8.989

3.  Lithium treatment for unipolar major depressive disorder: Systematic review.

Authors:  Juan Undurraga; Kang Sim; Leonardo Tondo; Ariel Gorodischer; Emilio Azua; Kai Hong Tay; David Tan; Ross J Baldessarini
Journal:  J Psychopharmacol       Date:  2019-01-30       Impact factor: 4.153

Review 4.  Relationship between suicide mortality and lithium in drinking water: A systematic review and meta-analysis.

Authors:  Fateme Barjasteh-Askari; Mojtaba Davoudi; Homayoun Amini; Mohammad Ghorbani; Mehdi Yaseri; Masoud Yunesian; Amir Hossein Mahvi; David Lester
Journal:  J Affect Disord       Date:  2019-12-19       Impact factor: 4.839

Review 5.  Borderline personality disorder and depression: an update.

Authors:  Maria Luca; Antonina Luca; Carmela Calandra
Journal:  Psychiatr Q       Date:  2012-09

6.  Psychosocial and psychiatric factors preceding death by suicide: A case-control psychological autopsy study involving multiple data sources.

Authors:  Elaine M McMahon; Birgit A Greiner; Paul Corcoran; Celine Larkin; Sara Leitao; Jacklyn McCarthy; Eugene Cassidy; Colin Bradley; Carmel McAuliffe; Eve Griffin; Eileen Williamson; Tom Foster; John Gallagher; Ivan J Perry; Nav Kapur; Ella Arensman
Journal:  Suicide Life Threat Behav       Date:  2022-07-11

Review 7.  Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.

Authors:  Konstantinos N Fountoulakis; Mauricio Tohen; Carlos A Zarate
Journal:  Eur Neuropsychopharmacol       Date:  2022-01       Impact factor: 4.600

8.  Lithium in drinking water and suicide risk.

Authors:  Tomoyuki Kawada
Journal:  EXCLI J       Date:  2022-03-03       Impact factor: 4.022

Review 9.  Review of lithium effects on brain and blood.

Authors:  Wise Young
Journal:  Cell Transplant       Date:  2009-05-13       Impact factor: 4.064

10.  Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial.

Authors:  Francesca Girlanda; Andrea Cipriani; Emilia Agrimi; Maria Grazia Appino; Andrea Barichello; Rossella Beneduce; Irene Bighelli; Giulia Bisoffi; Alfredo Bisogno; Paola Bortolaso; Marianna Boso; Carmela Calandra; Liliana Cascone; Mariasole Castellazzi; Caterina Corbascio; Vincenzo Fricchione Parise; Francesco Gardellin; Daniele Gennaro; Batul Hanife; Camilla Lintas; Marina Lorusso; Antonina Luca; Maria Luca; Chiara Luchetta; Claudio Lucii; Francesca Maio; Alessandra Marsilio; Chiara Mattei; Daniele Moretti; Michela Nosè; Guglielmo Occhionero; Duccio Papanti; Damiano Pecile; Mauro Percudani; Davide Prestia; Marianna Purgato; Francesco Restaino; Salvatore Romeo; Tiziana Sciarma; Stefania Strizzolo; Stefania Tamborini; Orlando Todarello; Fiorella Tozzi; Simona Ziero; Spyridon Zotos; Corrado Barbui
Journal:  BMC Res Notes       Date:  2014-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.